Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom

被引：0
|
作者：
Anette Woehl
Mark Evans
Anthony P Tetlow
Philip McEwan
机构：
[1] Cardiff University,School of Mathematics
[2] University Hospital of Wales,Department of Diabetes, Endocrinology and Metabolism
[3] Cardiff Research Consortium,undefined
来源：
Cardiovascular Diabetology | / 7卷
关键词：
Glycaemic Control; Insulin Glargine; Exenatide; Severe Hypoglycaemia; United Kingdom Prospective Diabetes Study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Medication compliance and persistency in patients with type 2 diabetes initiating exenatide or insulin glargine
    Fabunmi, R.
    Nielsen, L.
    Wade, R.
    Quimbo, R.
    Schroeder, B.
    Massoudi, M.
    Misurski, D.
    Wintle, M.
    [J]. DIABETOLOGIA, 2008, 51 : S352 - S352
  • [42] Cost-effectiveness analysis of insulin detemir compared to NPH insulin in patients with type-2 diabetes in the United Kingdom
    Smith, I
    Palmer, AJ
    Roze, S
    Kennedy-Martin, T
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 735 - 736
  • [43] COST SAVINGS IN TYPE-2 DIABETES (T2D) WITH INSULIN GLARGINE COMPARED WITH INSULIN DETEMIR IN THE UNITED KINGDOM
    Tilling, C.
    Evans, L. M.
    Keech, M.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A96 - A96
  • [44] COST-EFFECTIVENESS ANALYSIS OF BIPHASIC INSULIN ASPART VERSUS INSULIN GLARGINE IN PEOPLE WITH TYPE 2 DIABETES IN CHINA
    Xu, Z.
    Han, P.
    Wei, Y.
    Zhang, Y.
    Wu, J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A247 - A247
  • [45] The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes
    McEwan, P.
    Poole, C. D.
    Holmes, P.
    Tetlow, A. P.
    Currie, C. J.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A225 - A226
  • [46] Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia
    Nebojša Lalić
    Monika Russel-Szymczyk
    Marina Culic
    Christian Klyver Tikkanen
    Barrie Chubb
    [J]. Diabetes Therapy, 2018, 9 : 1201 - 1216
  • [47] Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia
    Lalic, Nebojsa
    Russel-Szymczyk, Monika
    Culic, Marina
    Tikkanen, Christian Klyver
    Chubb, Barrie
    [J]. DIABETES THERAPY, 2018, 9 (03) : 1201 - 1216
  • [48] Long-term evaluation of the cost-effectiveness of biphasic insulin aspart 30 versus insulin glargine in poorly controlled patients with type 2 diabetes receiving oral antidiabetic agents
    Cobden, D
    Palmer, A
    Nicklasson, L
    Roze, S
    Garber, A
    [J]. DIABETOLOGIA, 2005, 48 : A336 - A336
  • [49] CAM Interest Reflects a Perceived Lack of Helpfulness of Health Care for Motivated Patients with Sub-Optimally Controlled Type 2 Diabetes
    Bradley, Ryan
    Sherman, Karen
    Catz, Sheryl
    Calabrese, Carlo
    Jordan, Luesa
    Grothaus, Lou
    Cherkin, Dan C.
    [J]. DIABETES, 2011, 60 : A221 - A221
  • [50] Long-term cost-effectiveness of insulin aspart versus soluble human insulin in patients with type 1 diabetes in the United Kingdom
    Minshall, ME
    Twena, NS
    Nicklasson, L
    Roze, S
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 358 - 359
12345